From intuition to molecular profiles

A patient today with symptoms of Rheumatoid Arthritis will be diagnosed with a subjective survey that assesses mainly symptoms, but no molecular context. We aim to change this and enable Precision Medicine to treat and eventually cure inflammatory diseases—or even prevent them entirely.

An ecosystem for algorithm-based Precision Medicine

Our unique science and technology, along with our business leadership, will create a new ecosystem for diagnostics and disease/health management of inflammatory diseases. This ecosystem will enable precise diagnostics as well as treatment and intervention in very early preclinical stages.

Winning against chronic inflammatory diseases

Our goal is to enable disease-free remission or even prevention of major chronic inflammatory diseases, something that is rarely achieved currently.

"Clinical laboratory services are central to advances in
genomics, precision medicine, and drug development."
Steve Rusckowski, President and CEO of Quest Diagnostics, July 2015.